Related Experiment Videos
Postoperative radiotherapy after prostatectomy can be associated with severe side effects
M Edgren1, B Lennernäs, M Häggman
1Radiumhemmet, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden.
Anticancer Research
|August 15, 2001
Summary
Post-prostatectomy external beam radiation therapy (XRT) shows promise for improving local control in prostate cancer. However, a short time interval between surgery and XRT may increase severe side effects.
Area of Science:
- Oncology
- Radiation Oncology
- Urologic Oncology
Background:
- External beam radiation therapy (XRT) is a treatment option for prostate cancer.
- Post-prostatectomy XRT is used to manage local recurrence.
- Optimizing the timing of XRT after surgery is crucial for balancing efficacy and toxicity.
Purpose of the Study:
- To evaluate the efficacy and side effects of post-prostatectomy XRT.
- To assess the impact of a short time interval between surgery and XRT.
- To determine optimal timing for postoperative radiotherapy in prostate adenocarcinoma.
Main Methods:
- Retrospective study design.
- Inclusion of 16 patients with prostate adenocarcinoma.
- Analysis of outcomes including disease recurrence, survival, and side effects.
Main Results:
- 3 deaths due to disease recurrence and 2 relapses observed.
- Average follow-up of 60 months.
- Severe side effects occurred in some patients, with 2 requiring surgical intervention.
Conclusions:
- Postoperative XRT can improve local control in prostate cancer.
- A short interval between surgery and XRT may be associated with increased toxicity.
- A time interval of 3-6 months between surgery and postoperative radiotherapy is recommended.